Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 5
1993 20
1994 24
1995 33
1996 28
1997 28
1998 34
1999 20
2000 43
2001 34
2002 39
2003 48
2004 50
2005 41
2006 48
2007 43
2008 33
2009 28
2010 37
2011 23
2012 23
2013 34
2014 24
2015 23
2016 31
2017 17
2018 15
2019 14
2020 10
2021 6
Text availability
Article attribute
Article type
Publication date

Search Results

800 results
Results by year
Filters applied: . Clear all
Page 1
The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia.
McConnell JD, Roehrborn CG, Bautista OM, Andriole GL Jr, Dixon CM, Kusek JW, Lepor H, McVary KT, Nyberg LM Jr, Clarke HS, Crawford ED, Diokno A, Foley JP, Foster HE, Jacobs SC, Kaplan SA, Kreder KJ, Lieber MM, Lucia MS, Miller GJ, Menon M, Milam DF, Ramsdell JW, Schenkman NS, Slawin KM, Smith JA; Medical Therapy of Prostatic Symptoms (MTOPS) Research Group. McConnell JD, et al. N Engl J Med. 2003 Dec 18;349(25):2387-98. doi: 10.1056/NEJMoa030656. N Engl J Med. 2003. PMID: 14681504 Free article. Clinical Trial.
Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial.
Williams B, MacDonald TM, Morant S, Webb DJ, Sever P, McInnes G, Ford I, Cruickshank JK, Caulfield MJ, Salsbury J, Mackenzie I, Padmanabhan S, Brown MJ; British Hypertension Society's PATHWAY Studies Group. Williams B, et al. Lancet. 2015 Nov 21;386(10008):2059-2068. doi: 10.1016/S0140-6736(15)00257-3. Epub 2015 Sep 20. Lancet. 2015. PMID: 26414968 Free PMC article. Clinical Trial.
Efficacy of α-Blockers on Hemodynamic Control during Pheochromocytoma Resection: A Randomized Controlled Trial.
Buitenwerf E, Osinga TE, Timmers HJLM, Lenders JWM, Feelders RA, Eekhoff EMW, Haak HR, Corssmit EPM, Bisschop PHLT, Valk GD, Veldman RG, Dullaart RPF, Links TP, Voogd MF, Wietasch GJKG, Kerstens MN. Buitenwerf E, et al. J Clin Endocrinol Metab. 2020 Jul 1;105(7):2381-91. doi: 10.1210/clinem/dgz188. J Clin Endocrinol Metab. 2020. PMID: 31714582 Free PMC article. Clinical Trial.
Doxazosin in the current treatment of hypertension.
Wykretowicz A, Guzik P, Wysocki H. Wykretowicz A, et al. Expert Opin Pharmacother. 2008 Mar;9(4):625-33. doi: 10.1517/14656566.9.4.625. Expert Opin Pharmacother. 2008. PMID: 18312163 Review.
Doxazosin and congestive heart failure.
Sica DA. Sica DA. Congest Heart Fail. 2002 May-Jun;8(3):178-84. doi: 10.1111/j.1527-5299.2002.00939.x. Congest Heart Fail. 2002. PMID: 12045387 Free article. Review.
Commentary: Doxazosin for alcoholism.
Leggio L, Kenna GA. Leggio L, et al. Alcohol Clin Exp Res. 2013 Feb;37(2):191-3. doi: 10.1111/acer.12064. Epub 2012 Dec 27. Alcohol Clin Exp Res. 2013. PMID: 23278505 Free PMC article.
800 results